Skip to main content
main-content

Stroke

16-02-2017 | Arrhythmia | Main feed | Article

Real-world effectiveness, safety of novel oral anticoagulants in AF explored

A Danish nationwide cohort study published in The BMJ examines the effectiveness and safety profiles of novel oral anticoagulants among patients with atrial fibrillation.

Source:

BMJ 2017; 356: j510

16-02-2017 | Stroke | News | Article

News in brief

Arterial spin labeling detects post-stroke collateral blood vessels to aid prognosis

 Collateral blood vessels detected on arterial spin labeling magnetic resonance imaging are significantly associated with good neurologic outcomes in patients after acute ischemic stroke.

08-02-2017 | Stroke | Highlight | Article

Prolonged ECG monitoring improves post-stroke atrial fibrillation detection

Research suggests that all patients aged 60 years or older who have had a stroke, irrespective of the suspected cause, could benefit from enhanced and prolonged monitoring for atrial fibrillation.

Source:

Lancet Neurol 2017; Advance online publication

13-01-2017 | Stroke | News | Article

Migraine linked to stroke risk after surgery

Surgical patients with a history of migraine are at increased risk for perioperative ischemic stroke and hospital readmission within 30 days, study findings indicate.

Source:

BMJ 2017; 356: i6635

12-01-2017 | Stroke | News | Article

Editor's pick

No CLEAR functional benefits for alteplase in intraventricular hemorrhage removal

Irrigation with alteplase to remove intraventricular hemorrhage in patients with intracerebral hemorrhage and a routine extraventricular drain does not substantially improve functional outcome, indicate findings from the CLEAR III trial.

Source:

Lancet 2017; Advance online publication

06-01-2017 | Thrombosis | News | Article

News in brief

Targeting PAR4 ‘an attractive antiplatelet strategy’

Results of a study conducted in primates suggest that a novel protease-activated receptor-4 antagonist could reduce thrombus formation with a lower bleeding risk than other antiplatelet agents.

image credits